Development of automated fluorescence microscopy methods to assist the diagnosis and treatment of human malignancies

摘要

Fluorescence microscopy is a powerful technique used in many biological laboratories. It is often used as anillustrative tool but in combination with manual efforts, valuable quantitative results can also be obtained. Thepotential of automated fluorescence microscopy has been clearly shown by the high-content and high throughputstudies performed in the pharmaceutical industry and more recently in specialized high throughput imaging facilities.Computer controlled image capture and analysis not only scales up the actual image capture process and dataproduction it also brings an important level of objectiveness into microscopy, a field otherwise suffering from aninherent human bias in the selection of which objects to study. There is a growing need for the technique to beavailable for “everyone”, as a regular microscopy tool in biological laboratories.This thesis illustrates that the combination of available and affordable techniques allow us to develop automatedmicroscopy methods, including automated capture and image analysis routines that can be applied to answerdifferent biological questions. We show that a visual programming language enable us to make flexible applicationsfor automated microscopy, without detailed knowledge of complex computer languages (Paper I, Paper III - PaperVI).Using our automated fluorescence imaging and analysis method, in combination with a fluid dispenser robot fordrug printing, we have developed an assay for high throughput drug sensitivity testing. In Paper III, we studied theeffect of 29 different cytostatic drugs on 17 different lymphoblastoid cell lines. These cell lines are good in vitromodels for the post-transplant lymphoproliferative disease (PTLD), and the aim of this study was to characterizewhich drugs would be optimal in the treatment of these patients. Summarizing the effect of each drug on all 17LCLs, we identified epirubicin and paclitaxel as drugs that were highly effective (even at low concentrations). Thesame microscopy method was applied in combination with an analysis program that could identify and countdifferentially labelled cells in co-cultures. Using this approach, we could characterize which cytostatic drugs affectNK cell cytotoxicity negatively (Paper IV). Our data suggested that chemotherapy protocols including proteosomeinhibitors (such as bortezomib) or anti-microtubule drugs (paclitaxel, docetaxel and vinblastine) may interfere withNK cell-based immunotherapy, if applied simultaneously. Taken together, these two studies suggested that our drugsensitivity test might prove useful in assisting the design of optimal and individualized treatment protocols forcancer patients.In Paper V and VI, we have applied the technique in an approach to study neighbour suppression by fibroblasts ontumor cell proliferation, in an attempt to mimic in vitro a possible microenvironmental control function in vivo. Thesetwo studies demonstrated that the culture of tumor cells on monolayer of primary fibroblasts, might lead to eithergrowth stimulation or growth inhibition of tumor cells. Fibroblasts derived from the prostate of patients diagnosedwith prostate carcinoma (potential CAFs) were the least inhibiting, and occasionally even promoting tumor cellproliferation. However, fibroblasts derived from the skin of pediatric patients were highly represented in the groupof the most inhibitory fibroblasts. Our high-throughput study, with over 500 heterotypic cell combinations, withfour independent measurements for each sample and individual counting of each tumor cell, indicated that theeffect of fibroblasts on tumor cell proliferation was predominantly inhibitory. The technique allowed us to identifyfibroblasts with consistently high and with consistently low inhibitory capacity. These are valuable fibroblasts to usein further studies to understand the mechanism behind inhibition and its possible clinical relevance. In Paper VI wespecifically investigated the role of the structure of the fibroblast monolayer. We found that it was clearly notsufficient to have the inhibitory fibroblasts present in the mixed cell culture but that they also had to form aconfluent and sufficiently matured, intact monolayer to exert the inhibitory effect. Our data suggested thatstructured accumulation and deposition of extracellular matrix molecules might provide orientation dependentbehavioral cues to the tumor cell in an un-manipulated, inhibitory monolayer. Preliminary gene profiling suggestedmultiple differences in the signature of inhibitory and non-inhibitory fibroblasts.